NYSE American News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 53,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "49d82929-c9d6-4cbe-bf83-1bcf7c286ed9",
"title": "Q4 2023 Sierra Metals Inc Earnings Call Transcript",
"description": "Mar 18, 2024 / 03:00PM GMTOperator Thank you for standing by. This is the conference operator welcome to the Sierra Metals Inc, fourth quarter 2023 financial an",
"keywords": "GuruFocus, Article, News, GuruFocus Research, OTCPK:SMTSF",
"snippet": "Mar 18, 2024 / 03:00PM GMT\n\nOperator\n\n\n\nThank you for standing by. This is the conference operator welcome to the Sierra Metals Inc, fourth quarter 2023 financi...",
"url": "https://www.gurufocus.com/news/2385910/q4-2023-sierra-metals-inc-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-03-19T05:00:20.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SMTS",
"name": "Sierra Metals Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 138.70508,
"sentiment_score": 0.4434,
"highlights": [
{
"highlight": "This is the conference operator welcome to the <em>Sierra</em> <em>Metals</em> <em>Inc</em>, fourth quarter 2023 financial and operating results conference call. (Operator Instructions) And the conference is being recorded. I would now like to turn the conference over to Jean Pierre Fort Del Rio, Manager of Business Development and Investor Relations for <em>Sierra</em> <em>Metals</em>.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Jean Pierre Fort Del Rio - <em>Sierra</em> <em>Metals</em> <em>Inc</em>. - IR\n\n\n\nGood morning, everyone. I'd like to note that this earnings call contains forward-looking information that is based on the company's expectations, estimates, and beliefs.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Q4 2023 <em>Sierra</em> <em>Metals</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "db1f379a-ecdd-419d-b953-d0ed96a3e38d",
"title": "Director Geoffrey Barker Acquires 50,000 Shares of Laird Superfood Inc (LSF)",
"description": "On March 15, 2024, Geoffrey Barker, a Director at Laird Superfood Inc (LSF), executed a purchase of 50,000 shares of the company, according to a recent SEC Fili",
"keywords": "GuruFocus, Article, News, GuruFocus Research, LSF",
"snippet": "On March 15, 2024, Geoffrey Barker, a Director at Laird Superfood Inc (LSF, Financial), executed a purchase of 50,000 shares of the company, according to a rece...",
"url": "https://www.gurufocus.com/news/2385879/director-geoffrey-barker-acquires-50000-shares-of-laird-superfood-inc-lsf",
"image_url": "https://static.gurufocus.com/logos/0C0000BYD2.png?12",
"language": "en",
"published_at": "2024-03-19T04:08:34.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "LSF",
"name": "Laird Superfood, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 167.12262,
"sentiment_score": 0.54014,
"highlights": [
{
"highlight": "On March 15, 2024, Geoffrey Barker, a Director at <em>Laird</em> <em>Superfood</em> <em>Inc</em> (LSF, Financial), executed a purchase of 50,000 shares of the company, according to a recent SEC Filing. This transaction has expanded Geoffrey Barker's holdings in the company, reflecting a significant vote of confidence in the firm's prospects.",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Laird</em> <em>Superfood</em> <em>Inc</em> is a company that specializes in the production and distribution of plant-based superfood products. These products are designed to enhance overall health and performance, catering to a growing market of health-conscious consumers.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "The insider transaction history for <em>Laird</em> <em>Superfood</em> <em>Inc</em> shows a pattern of insider confidence, with 5 insider buys and no insider sells over the past year.\n\nOn the valuation front, <em>Laird</em> <em>Superfood</em> Inc's shares were trading at $2.79 on the day of the insider's purchase, giving the company a market capitalization of $24.196 million.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "The recent purchase by Director Geoffrey Barker may suggest a positive outlook for <em>Laird</em> <em>Superfood</em> <em>Inc</em>, although the market valuation metrics indicate a premium above the GF Value estimate.\n\nThis article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice.",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "Director Geoffrey Barker Acquires 50,000 Shares of <em>Laird</em> <em>Superfood</em> <em>Inc</em> (LSF)",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "81fdfc23-1b01-4968-9d33-1bc6a6f25542",
"title": "My 9% Income Portfolio–Harmony In Investment",
"description": "My portfolio today has a certain number of CEFs and ETFs that are suffering from the point of view of NAV performance. Click here for an analysis of my portfolio.",
"keywords": "",
"snippet": "Castle of Brolio, Chianti, Tuscany. Uwe Moser/iStock Editorial via Getty Images\n\nChianti and the Harmony of Landscape\n\nAlong the Via Chiantigiana, which connect...",
"url": "https://seekingalpha.com/article/4679027-my-9-percent-income-portfolio-harmony-in-investment",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1757998775/image_1757998775.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-19T03:34:32.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "^JEPI-NV",
"name": "JPMORGAN EQUITY PREMIUM INCOME ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 22.485458,
"sentiment_score": 0.567533,
"highlights": [
{
"highlight": "Special Opportunities Fund (SPE)\n\nCohen & Steers Infrastructure (UTF)\n\nReaves Utility Income Trust (UTG)\n\nXAI Octagon Floating Rate & Alternative Income Trust (XFLT)\n\nGiotto Income Portfolio (named after the fourteenth-century Florentine painter and architect) includes five ETFs and one ETN with monthly distributions that adopt a covered-call strategy:\n\n<em>JPMorgan</em>",
"sentiment": 0.9118,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Equity</em> <em>Premium</em> <em>Income</em> (JEPI)\n\nJPMorgan Nasdaq Equity Premium Income (JEPQ)\n\nGlobal X Nasdaq 100 Covered Call (QYLD)\n\nGlobal X Russell 2000 Covered Call (RYLD)\n\nCredit Suisse X-Links Crude Oil Shares Covered Call ETNs (USOI)\n\nGlobal X S&P 500 Covered Call (XYLD)\n\nMasaccio Income Portfolio (named after the founder of Renaissance painting) contains three",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "PIMCO Corporate & Income Strategy\n\nPrice Performance (Morningstar, Author)\n\n<em>JPMorgan</em> <em>Equity</em> <em>Premium</em> <em>Income</em>\n\nPrice Performance (Morningstar, Author)\n\nBlackRock Science And Technology Trust\n\nPrice Performance (Morningstar, Author)\n\nJohn Hancock Premium Dividend\n\nPrice Performance (Morningstar, Author)\n\nXAI Octagon FR & Alt Income Term Trust\n\nPrice Performance",
"sentiment": 0.765,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^JEPI-TC",
"name": "JPMORGAN EQUITY PREMIUM INCOME ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 22.485458,
"sentiment_score": 0.567533,
"highlights": [
{
"highlight": "Special Opportunities Fund (SPE)\n\nCohen & Steers Infrastructure (UTF)\n\nReaves Utility Income Trust (UTG)\n\nXAI Octagon Floating Rate & Alternative Income Trust (XFLT)\n\nGiotto Income Portfolio (named after the fourteenth-century Florentine painter and architect) includes five ETFs and one ETN with monthly distributions that adopt a covered-call strategy:\n\n<em>JPMorgan</em>",
"sentiment": 0.9118,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Equity</em> <em>Premium</em> <em>Income</em> (JEPI)\n\nJPMorgan Nasdaq Equity Premium Income (JEPQ)\n\nGlobal X Nasdaq 100 Covered Call (QYLD)\n\nGlobal X Russell 2000 Covered Call (RYLD)\n\nCredit Suisse X-Links Crude Oil Shares Covered Call ETNs (USOI)\n\nGlobal X S&P 500 Covered Call (XYLD)\n\nMasaccio Income Portfolio (named after the founder of Renaissance painting) contains three",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "PIMCO Corporate & Income Strategy\n\nPrice Performance (Morningstar, Author)\n\n<em>JPMorgan</em> <em>Equity</em> <em>Premium</em> <em>Income</em>\n\nPrice Performance (Morningstar, Author)\n\nBlackRock Science And Technology Trust\n\nPrice Performance (Morningstar, Author)\n\nJohn Hancock Premium Dividend\n\nPrice Performance (Morningstar, Author)\n\nXAI Octagon FR & Alt Income Term Trust\n\nPrice Performance",
"sentiment": 0.765,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^JEPI-EU",
"name": "JPMORGAN EQUITY PREMIUM INCOME ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 22.485458,
"sentiment_score": 0.567533,
"highlights": [
{
"highlight": "Special Opportunities Fund (SPE)\n\nCohen & Steers Infrastructure (UTF)\n\nReaves Utility Income Trust (UTG)\n\nXAI Octagon Floating Rate & Alternative Income Trust (XFLT)\n\nGiotto Income Portfolio (named after the fourteenth-century Florentine painter and architect) includes five ETFs and one ETN with monthly distributions that adopt a covered-call strategy:\n\n<em>JPMorgan</em>",
"sentiment": 0.9118,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Equity</em> <em>Premium</em> <em>Income</em> (JEPI)\n\nJPMorgan Nasdaq Equity Premium Income (JEPQ)\n\nGlobal X Nasdaq 100 Covered Call (QYLD)\n\nGlobal X Russell 2000 Covered Call (RYLD)\n\nCredit Suisse X-Links Crude Oil Shares Covered Call ETNs (USOI)\n\nGlobal X S&P 500 Covered Call (XYLD)\n\nMasaccio Income Portfolio (named after the founder of Renaissance painting) contains three",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "PIMCO Corporate & Income Strategy\n\nPrice Performance (Morningstar, Author)\n\n<em>JPMorgan</em> <em>Equity</em> <em>Premium</em> <em>Income</em>\n\nPrice Performance (Morningstar, Author)\n\nBlackRock Science And Technology Trust\n\nPrice Performance (Morningstar, Author)\n\nJohn Hancock Premium Dividend\n\nPrice Performance (Morningstar, Author)\n\nXAI Octagon FR & Alt Income Term Trust\n\nPrice Performance",
"sentiment": 0.765,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "0aecc88a-2508-4b99-9c5b-0cd04232966e",
"title": "SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX -March 18, 2024 at 10:53 pm EDT",
"description": "NEW YORK, March 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...",
"keywords": "Markets",
"snippet": "NEW YORK, March 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the...",
"url": "https://www.marketscreener.com/quote/stock/VIVAKOR-INC-120792710/news/SHAREHOLDER-UPDATE-Halper-Sadeh-LLC-Investigates-VIVK-MINM-SDPI-AKTX-46226685/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
"language": "en",
"published_at": "2024-03-19T02:53:03.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "SDPI",
"name": "Superior Drilling Products, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 36.82727,
"sentiment_score": 0.5423,
"highlights": [
{
"highlight": "<em>Superior</em> <em>Drilling</em> <em>Products</em>, <em>Inc</em>. (NYSE: SDPI)'s sale to Drilling Tools International Corp. for approximately $32.2 million in cash and Drilling Tools stock. If you are a Superior Drilling shareholder, click here to learn more about your rights and options.\n\nAkari Therapeutics, Plc (NASDAQ: AKTX)'s merger with Peak Bio Inc.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "522d0d39-a0bb-49d3-b746-e2688e4518bc",
"title": "New ASEAN Energy and ACTUAL Sign Cooperation Agreement to Develop Net-Zero Plan for the New $5B USD Pengerang Energy Complex",
"description": "",
"keywords": "",
"snippet": "New ASEAN Energy and ACTUAL Sign Cooperation Agreement to Develop Net-Zero Plan for the New $5B USD Pengerang Energy Complex\n\n\n\n\n\n\n\n\n\nNew ASEAN Energy and ACTUA...",
"url": "https://www.startup365.fr/new-asean-energy-and-actual-sign-cooperation-agreement-to-develop-net-zero-plan-for-the-new-5b-usd-pengerang-energy-complex/",
"image_url": "",
"language": "fr",
"published_at": "2024-03-19T02:18:31.000000Z",
"source": "startup365.fr",
"relevance_score": null,
"entities": [
{
"symbol": "GDP",
"name": "Goodrich Petroleum Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 25.203808,
"sentiment_score": null,
"highlights": [
{
"highlight": "previously served as the Vice Chairman & Global Head of Natural Resources & Clean Energy Transition for Citi Bank, Vice Chairman & Global Head of Energy for UBS, Managing Director and Head of Energy for Morgan Stanley and Vice President of Energy M&A Group for Credit Suisse First Boston\n\nRobert Turnham, former President, Director and founding partner of <em>Goodrich</em>",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Petroleum</em> <em>Corporation</em>, a public exploration and production company for 26 years\n\nNeil Bush, Chairman of Atlas Renewable Inc, Co-Chairman of CIIC, Chairman of A&A Investments, Chairman of the George HW Bush Foundation for US China Relations, and Chairman of the Bush School of Government and Public Service Advisory Board\n\nLaique Rehman, founder and Chief",
"sentiment": null,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "209b66bb-f0f8-44b7-a6b0-5e7e265ddbfa",
"title": "ROBT ETF: Too Diversified For Reliable Alpha (NASDAQ:ROBT)",
"description": "The First Trust AI & Robotics ETF offers focused exposure to automation and AI, but has underperformed the market in recent years. Read more on ROBT ETF here.",
"keywords": "",
"snippet": "SweetBunFactory/iStock via Getty Images\n\nInvesting in AI ETFs carries specific risks that I personally do not like to take on. Primarily, these relate to specul...",
"url": "https://seekingalpha.com/article/4679016-robt-too-diversified-for-reliable-alpha",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1654943682/image_1654943682.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-19T01:32:19.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "^ARKK-NV",
"name": "ARK Innovation ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 16.474426,
"sentiment_score": 0.8646,
"highlights": [
{
"highlight": "This can also be seen in companies like Tesla (TSLA), Zoom (ZM), and the <em>ARK</em> <em>Innovation</em> <em>ETF</em> (ARKK):\n\nAuthor, Using Seeking Alpha\n\nFrom my analysis, although the significant valuation premium continues for many of the firms listed in the ROBT ETF, investors can be more confident they are getting a good deal at present valuations than in 2021.",
"sentiment": 0.8646,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^ARKK-EU",
"name": "ARK Innovation ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 16.474426,
"sentiment_score": 0.8646,
"highlights": [
{
"highlight": "This can also be seen in companies like Tesla (TSLA), Zoom (ZM), and the <em>ARK</em> <em>Innovation</em> <em>ETF</em> (ARKK):\n\nAuthor, Using Seeking Alpha\n\nFrom my analysis, although the significant valuation premium continues for many of the firms listed in the ROBT ETF, investors can be more confident they are getting a good deal at present valuations than in 2021.",
"sentiment": 0.8646,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^ARKK-TC",
"name": "ARK Innovation ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 16.474384,
"sentiment_score": 0.8646,
"highlights": [
{
"highlight": "This can also be seen in companies like Tesla (TSLA), Zoom (ZM), and the <em>ARK</em> <em>Innovation</em> <em>ETF</em> (ARKK):\n\nAuthor, Using Seeking Alpha\n\nFrom my analysis, although the significant valuation premium continues for many of the firms listed in the ROBT ETF, investors can be more confident they are getting a good deal at present valuations than in 2021.",
"sentiment": 0.8646,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^ARKK-IV",
"name": "ARK Innovation ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 16.474384,
"sentiment_score": 0.8646,
"highlights": [
{
"highlight": "This can also be seen in companies like Tesla (TSLA), Zoom (ZM), and the <em>ARK</em> <em>Innovation</em> <em>ETF</em> (ARKK):\n\nAuthor, Using Seeking Alpha\n\nFrom my analysis, although the significant valuation premium continues for many of the firms listed in the ROBT ETF, investors can be more confident they are getting a good deal at present valuations than in 2021.",
"sentiment": 0.8646,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "84efd2f0-5ef6-4c04-9407-d8f19b5d7127",
"title": "ICVT ETF: Could Be In Line For Growth (BATS:ICVT)",
"description": "iShares Convertible Bond ETF has been stagnant compared to broader U.S. indices despite strong equity markets. Click here for an update on ICVT.",
"keywords": "",
"snippet": "tadamichi\n\nThe iShares Convertible Bond ETF (BATS:ICVT) has been pretty stagnant relative to the broader U.S. indices since the beginning of the year. In our la...",
"url": "https://seekingalpha.com/article/4678931-icvt-could-be-in-line-for-growth",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1487894858/image_1487894858.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T17:17:39.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "^ICVT-EU",
"name": "iShares Convertible Bond ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 44.379097,
"sentiment_score": 0.765,
"highlights": [
{
"highlight": "tadamichi\n\nThe <em>iShares</em> <em>Convertible</em> <em>Bond</em> <em>ETF</em> (BATS:ICVT) has been pretty stagnant relative to the broader U.S. indices since the beginning of the year. In our last article, we made sure to focus on both the equity and the bond dynamics of convertibles, and we'll do the same again.",
"sentiment": 0.765,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^ICVT-NV",
"name": "iShares Convertible Bond ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 44.37893,
"sentiment_score": 0.765,
"highlights": [
{
"highlight": "tadamichi\n\nThe <em>iShares</em> <em>Convertible</em> <em>Bond</em> <em>ETF</em> (BATS:ICVT) has been pretty stagnant relative to the broader U.S. indices since the beginning of the year. In our last article, we made sure to focus on both the equity and the bond dynamics of convertibles, and we'll do the same again.",
"sentiment": 0.765,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^ICVT-IV",
"name": "iShares Convertible Bond ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 44.37893,
"sentiment_score": 0.765,
"highlights": [
{
"highlight": "tadamichi\n\nThe <em>iShares</em> <em>Convertible</em> <em>Bond</em> <em>ETF</em> (BATS:ICVT) has been pretty stagnant relative to the broader U.S. indices since the beginning of the year. In our last article, we made sure to focus on both the equity and the bond dynamics of convertibles, and we'll do the same again.",
"sentiment": 0.765,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^ICVT-TC",
"name": "iShares Convertible Bond ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 44.378914,
"sentiment_score": 0.765,
"highlights": [
{
"highlight": "tadamichi\n\nThe <em>iShares</em> <em>Convertible</em> <em>Bond</em> <em>ETF</em> (BATS:ICVT) has been pretty stagnant relative to the broader U.S. indices since the beginning of the year. In our last article, we made sure to focus on both the equity and the bond dynamics of convertibles, and we'll do the same again.",
"sentiment": 0.765,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ICVT",
"name": "iShares Convertible Bond ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 91.1966,
"sentiment_score": 0.5734,
"highlights": [
{
"highlight": "tadamichi\n\nThe <em>iShares</em> <em>Convertible</em> <em>Bond</em> <em>ETF</em> (<em>BATS:ICVT</em>) has been pretty stagnant relative to the broader U.S. indices since the beginning of the year. In our last article, we made sure to focus on both the equity and the bond dynamics of convertibles, and we'll do the same again.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "ICVT ETF: Could Be In Line For Growth (<em>BATS:ICVT</em>)",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "6af0fbcb-fc08-4494-8ac6-56e4b1635c0c",
"title": "IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF",
"description": "iShares U.S. Medical Devices ETF warrants a buy rating due to its top holdings' ability to capture strong returns. Read more to see my analysis on IHI.",
"keywords": "",
"snippet": "shapecharge\n\nInvestment Thesis\n\niShares U.S. Medical Devices ETF (NYSEARCA:IHI) warrants a buy rating due to multiple factors impacting the fund. While IHI has ...",
"url": "https://seekingalpha.com/article/4678930-ihi-technological-advances-will-continue-carrying-this-high-performing-medical-etf",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/592647720/image_592647720.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T17:15:32.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "^SPX",
"name": "S&P 500 INDEX",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 24.126259,
"sentiment_score": 0.71055,
"highlights": [
{
"highlight": "Of the funds compared, only IHI has outperformed the <em>S</em>&<em>P</em> <em>500</em> <em>Index</em> over the past decade.\n\n10-Year Total Price Return: IHI and Compared Health Care Funds (Seeking Alpha)\n\nAlthough IHI has demonstrated the greatest price return over the past 10 years, one downside is its fees.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the <em>S</em>&<em>P</em> <em>500</em> <em>Index</em> over the past year.\n\nOne-Year Performance: IHI and Peer Health Care & Medical Device ETFs (Seeking Alpha)\n\nOne downside for IHI is its current valuation compared to the peer funds examined.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ISRG",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 28.91593,
"sentiment_score": 0.625217,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, Abbott Laboratories (ABT) and <em>Intuitive</em> <em>Surgical</em>, <em>Inc</em>. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuitive</em> <em>Surgical</em>: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. <em>Intuitive</em> <em>Surgical</em> is well known for its development of the da Vinci surgical robotics system. Importantly for ISRG, the company received FDA approval for the da Vinci 5 just this past week.",
"sentiment": 0.7701,
"highlighted_in": "main_text"
},
{
"highlight": "In 2018, a class action lawsuit was settled by <em>Intuitive</em> <em>Surgical</em> for $42.5M. However, the company has continued to make updates, improvements, and released newer models. ISRG has seen a 69% price return over the past year and demonstrates strong fundamentals including a 14.5% YoY revenue growth and 25.4% net income margin.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "However, risks exist for the fund including lawsuits for medical devices and competition that will encroach on the successful products of Abbott and <em>Intuitive</em> <em>Surgical</em>. Finally, despite IHI’s track record for performance, it currently has a relatively high expense ratio and P/E ratio compared to peer funds.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABT",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.707993,
"sentiment_score": 0.64824,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, <em>Abbott</em> <em>Laboratories</em> (ABT) and Intuitive Surgical, Inc. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "Forecast Medical Device Market Growth, 2020-2030 (www.grandviewresearch.com)\n\n<em>Abbott</em> <em>Laboratories</em>: Fulfilling Heart and Glucose Monitoring Demand\n\nIHI’s top holding, ABT, is one key company poised to take advantage of this medical device industry growth. Abbott saw a strong 2023 with 11.6% increase in sales growth.",
"sentiment": 0.9633,
"highlighted_in": "main_text"
},
{
"highlight": "Therefore, <em>Abbott</em> <em>Laboratories</em> is a fundamental holding that will drive IHI’s future price return.\n\nIntuitive Surgical: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. Intuitive Surgical is well known for its development of the da Vinci surgical robotics system.",
"sentiment": 0.3129,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.799889,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.BA",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.79979,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABT.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.707397,
"sentiment_score": 0.64824,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, <em>Abbott</em> <em>Laboratories</em> (ABT) and Intuitive Surgical, Inc. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "Forecast Medical Device Market Growth, 2020-2030 (www.grandviewresearch.com)\n\n<em>Abbott</em> <em>Laboratories</em>: Fulfilling Heart and Glucose Monitoring Demand\n\nIHI’s top holding, ABT, is one key company poised to take advantage of this medical device industry growth. Abbott saw a strong 2023 with 11.6% increase in sales growth.",
"sentiment": 0.9633,
"highlighted_in": "main_text"
},
{
"highlight": "Therefore, <em>Abbott</em> <em>Laboratories</em> is a fundamental holding that will drive IHI’s future price return.\n\nIntuitive Surgical: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. Intuitive Surgical is well known for its development of the da Vinci surgical robotics system.",
"sentiment": 0.3129,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABTCL.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 36.707397,
"sentiment_score": 0.64824,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, <em>Abbott</em> <em>Laboratories</em> (ABT) and Intuitive Surgical, Inc. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "Forecast Medical Device Market Growth, 2020-2030 (www.grandviewresearch.com)\n\n<em>Abbott</em> <em>Laboratories</em>: Fulfilling Heart and Glucose Monitoring Demand\n\nIHI’s top holding, ABT, is one key company poised to take advantage of this medical device industry growth. Abbott saw a strong 2023 with 11.6% increase in sales growth.",
"sentiment": 0.9633,
"highlighted_in": "main_text"
},
{
"highlight": "Therefore, <em>Abbott</em> <em>Laboratories</em> is a fundamental holding that will drive IHI’s future price return.\n\nIntuitive Surgical: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. Intuitive Surgical is well known for its development of the da Vinci surgical robotics system.",
"sentiment": 0.3129,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PSCH",
"name": "Invesco S&P SmallCap Health Care ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 35.797073,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the SPDR S&P Health Care Equipment ETF (XHE), the <em>Invesco</em> <em>S</em>&<em>P</em> <em>SmallCap</em> <em>Health</em> <em>Care</em> <em>ETF</em> (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^JI0020.JO",
"name": "Health Care Index",
"exchange": null,
"exchange_long": null,
"country": "za",
"type": "index",
"industry": "N/A",
"match_score": 14.29501,
"sentiment_score": 0.8658,
"highlights": [
{
"highlight": "PSCH seeks to capture the performance of the S&P SmallCap600 Capped <em>Health</em> <em>Care</em> <em>Index</em>. The fund therefore includes small-cap value and growth holdings. VHT tracks the MSCI U.S. Investable Market Health Care 25/50 Index. The fund is passively managed and includes small, mid, and large cap holdings within the health care market sector in general.",
"sentiment": 0.8658,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "XHE",
"name": "SPDR S&P Health Care Equipment ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 32.55597,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> <em>ETF</em> (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "IHI",
"name": "iShares U.S. Medical Devices ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 32.704197,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "shapecharge\n\nInvestment Thesis\n\n<em>iShares</em> <em>U.S</em>. <em>Medical</em> <em>Devices</em> <em>ETF</em> (<em>NYSEARCA:IHI</em>) warrants a buy rating due to multiple factors impacting the fund. While IHI has the highest expense ratio compared to peer medical device and healthcare funds, it also has demonstrated the greatest long-term performance.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^XHE-NV",
"name": "SPDR S&P HEALTH CARE EQUIPMENT ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 27.135712,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> ETF (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^XHE-EU",
"name": "SPDR S&P HEALTH CARE EQUIPMENT ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 27.135658,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> ETF (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^XHE-IV",
"name": "SPDR S&P HEALTH CARE EQUIPMENT ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 27.135658,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> ETF (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^XHE-TC",
"name": "SPDR S&P HEALTH CARE EQUIPMENT ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 27.135658,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> ETF (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 17.024155,
"sentiment_score": 0.71055,
"highlights": [
{
"highlight": "Of the funds compared, only IHI has outperformed the <em>S</em>&<em>P</em> <em>500</em> Index over the past decade.\n\n10-Year Total Price Return: IHI and Compared Health Care Funds (Seeking Alpha)\n\nAlthough IHI has demonstrated the greatest price return over the past 10 years, one downside is its fees.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the <em>S</em>&<em>P</em> <em>500</em> Index over the past year.\n\nOne-Year Performance: IHI and Peer Health Care & Medical Device ETFs (Seeking Alpha)\n\nOne downside for IHI is its current valuation compared to the peer funds examined.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.DE",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.799873,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "IHI.MX",
"name": "iShares U.S. Medical Devices ETF",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "etf",
"industry": "N/A",
"match_score": 25.855957,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "shapecharge\n\nInvestment Thesis\n\n<em>iShares</em> <em>U.S</em>. <em>Medical</em> <em>Devices</em> <em>ETF</em> (NYSEARCA:IHI) warrants a buy rating due to multiple factors impacting the fund. While IHI has the highest expense ratio compared to peer medical device and healthcare funds, it also has demonstrated the greatest long-term performance.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ISRG.MX",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 28.917603,
"sentiment_score": 0.625217,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, Abbott Laboratories (ABT) and <em>Intuitive</em> <em>Surgical</em>, <em>Inc</em>. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuitive</em> <em>Surgical</em>: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. <em>Intuitive</em> <em>Surgical</em> is well known for its development of the da Vinci surgical robotics system. Importantly for ISRG, the company received FDA approval for the da Vinci 5 just this past week.",
"sentiment": 0.7701,
"highlighted_in": "main_text"
},
{
"highlight": "In 2018, a class action lawsuit was settled by <em>Intuitive</em> <em>Surgical</em> for $42.5M. However, the company has continued to make updates, improvements, and released newer models. ISRG has seen a 69% price return over the past year and demonstrates strong fundamentals including a 14.5% YoY revenue growth and 25.4% net income margin.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "However, risks exist for the fund including lawsuits for medical devices and competition that will encroach on the successful products of Abbott and <em>Intuitive</em> <em>Surgical</em>. Finally, despite IHI’s track record for performance, it currently has a relatively high expense ratio and P/E ratio compared to peer funds.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.MX",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.800976,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R29.L",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 28.916973,
"sentiment_score": 0.625217,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, Abbott Laboratories (ABT) and <em>Intuitive</em> <em>Surgical</em>, <em>Inc</em>. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuitive</em> <em>Surgical</em>: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. <em>Intuitive</em> <em>Surgical</em> is well known for its development of the da Vinci surgical robotics system. Importantly for ISRG, the company received FDA approval for the da Vinci 5 just this past week.",
"sentiment": 0.7701,
"highlighted_in": "main_text"
},
{
"highlight": "In 2018, a class action lawsuit was settled by <em>Intuitive</em> <em>Surgical</em> for $42.5M. However, the company has continued to make updates, improvements, and released newer models. ISRG has seen a 69% price return over the past year and demonstrates strong fundamentals including a 14.5% YoY revenue growth and 25.4% net income margin.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "However, risks exist for the fund including lawsuits for medical devices and competition that will encroach on the successful products of Abbott and <em>Intuitive</em> <em>Surgical</em>. Finally, despite IHI’s track record for performance, it currently has a relatively high expense ratio and P/E ratio compared to peer funds.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0Q1G.L",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 17.800919,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LILY34.SA",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.800636,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "I1SR34.SA",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 28.916515,
"sentiment_score": 0.625217,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, Abbott Laboratories (ABT) and <em>Intuitive</em> <em>Surgical</em>, <em>Inc</em>. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuitive</em> <em>Surgical</em>: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. <em>Intuitive</em> <em>Surgical</em> is well known for its development of the da Vinci surgical robotics system. Importantly for ISRG, the company received FDA approval for the da Vinci 5 just this past week.",
"sentiment": 0.7701,
"highlighted_in": "main_text"
},
{
"highlight": "In 2018, a class action lawsuit was settled by <em>Intuitive</em> <em>Surgical</em> for $42.5M. However, the company has continued to make updates, improvements, and released newer models. ISRG has seen a 69% price return over the past year and demonstrates strong fundamentals including a 14.5% YoY revenue growth and 25.4% net income margin.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "However, risks exist for the fund including lawsuits for medical devices and competition that will encroach on the successful products of Abbott and <em>Intuitive</em> <em>Surgical</em>. Finally, despite IHI’s track record for performance, it currently has a relatively high expense ratio and P/E ratio compared to peer funds.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "bab26555-b0ac-4463-a87d-d9a02f950e64",
"title": "Vista Gold Corp. (VGZ) Q4 2023 Earnings Call Transcript",
"description": "Vista Gold Corp. (NYSE:NYSE:VGZ) Q4 2023 Results Conference Call March 18, 2024 4:00 PM ETCompany ParticipantsPamela Solly - Vice President of Investor...",
"keywords": "",
"snippet": "Vista Gold Corp. (NYSE:VGZ) Q4 2023 Results Conference Call March 18, 2024 4:00 PM ET\n\nCompany Participants\n\nPamela Solly - Vice President of Investor Relations...",
"url": "https://seekingalpha.com/article/4679005-vista-gold-corp-vgz-q4-2023-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-03-18T23:22:02.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "VGZ",
"name": "Vista Gold Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 119.31442,
"sentiment_score": 0.7154,
"highlights": [
{
"highlight": "<em>Vista</em> <em>Gold</em> <em>Corp</em>. (NYSE:VGZ) Q4 2023 Results Conference Call March 18, 2024 4:00 PM ET\n\nCompany Participants\n\nPamela Solly - Vice President of Investor Relations\n\nFred Earnest - President and Chief Executive Officer\n\nDoug Tobler - Chief Financial Officer\n\nOperator\n\nGood day, ladies and gentlemen.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "Thank you for joining the <em>Vista</em> <em>Gold</em> 2023 Financial Results and Corporate Update Conference Call. I'm Pamela Solly, Vice President of Investor Relations. On the call today are Fred Earnest, President and Chief Executive Officer; and Doug Tobler, Chief Financial Officer.\n\nDuring the course of this call, we will be making forward-looking statements.",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "Randy and his passion for <em>Vista</em> <em>Gold</em> will be remembered and missed.\n\nAs we turn to our 2023 results, I'm pleased to report that, during 2023, we succeeded in efficiently managing our cash and strengthen our balance sheet by completing a $20 million royalty transaction between Wheaton Precious Metals.",
"sentiment": 0.9349,
"highlighted_in": "main_text"
},
{
"highlight": "Moving on, earlier this year, we also appointed Mike Sylvester as Director of <em>Vista</em> <em>Gold</em> and a member of our Health, Safety, Environment and Social Responsibility Committee. Mr. Sylvester is a successful mining executive with over 45 years of international and domestic industry experience with major, mid-tier and junior companies.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "We believe that, <em>Vista</em> <em>Gold</em> represents an exceptional investment opportunity and that current prices represent a tremendous opportunity to establish a position or increase one's holdings in <em>Vista</em> <em>Gold</em>.\n\nWe'll now respond to any questions from participants on this call.\n\nQuestion-and-Answer Session\n\nOperator\n\nFred Earnest\n\nVery well.",
"sentiment": 0.9157,
"highlighted_in": "main_text"
},
{
"highlight": "We invite you to seriously consider the opportunity that is presented by an investment in <em>Vista</em> <em>Gold</em>. We think that, there is a tremendous value-creation opportunity here and we would love for each of you who are on the call today to be part of that.\n\nWith that, I thank you for your time and wish each of you a very pleasant afternoon.",
"sentiment": 0.9568,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Vista</em> <em>Gold</em> <em>Corp</em>. (VGZ) Q4 2023 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "41e34e10-db8e-429e-aff6-fcac06b07fae",
"title": "SAVE THE DATE: NOVAGOLD 2024 First Quarter Financial Results Release, Conference Call and Video Webcast",
"description": "VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) —",
"keywords": "",
"snippet": "SAVE THE DATE: NOVAGOLD 2024 First Quarter Financial Results Release, Conference Call and Video Webcast\n\nArticle content\n\nVANCOUVER, British Columbia, March 18,...",
"url": "https://financialpost.com/globe-newswire/save-the-date-novagold-2024-first-quarter-financial-results-release-conference-call-and-video-webcast",
"image_url": "https://dcs-static.gprod.postmedia.digital/15.6.0/websites/images/fp/favicon-fp.ico",
"language": "en",
"published_at": "2024-03-18T21:09:43.000000Z",
"source": "financialpost.com",
"relevance_score": null,
"entities": [
{
"symbol": "NG",
"name": "NovaGold Resources Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 49.620327,
"sentiment_score": 0.6037,
"highlights": [
{
"highlight": "SAVE THE DATE: NOVAGOLD 2024 First Quarter Financial Results Release, Conference Call and Video Webcast\n\nArticle content\n\nVANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) — <em>NOVAGOLD</em> <em>RESOURCES</em> <em>INC</em>. (TSX, NYSE American: NG) will release its 2024 first quarter financial results after market close on April 3, 2024.",
"sentiment": 0.6037,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "45e909ae-06fa-4b2d-b1b7-7f28ffce4be9",
"title": "SAVE THE DATE: NOVAGOLD 2024 First Quarter Financial Results Release, Conference Call and Video Webcast -March 18, 2024 at 05:06 pm EDT",
"description": "VANCOUVER, British Columbia, March 18, 2024 -- NOVAGOLD RESOURCES INC. will release its 2024 first quarter financial results after market close on April 3, 2024. A conference call and video...",
"keywords": "Markets",
"snippet": "VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (TSX, NYSE American: NG) will release its 2024 first quarter financial r...",
"url": "https://www.marketscreener.com/quote/stock/NOVAGOLD-RESOURCES-INC-1410991/news/SAVE-THE-DATE-NOVAGOLD-2024-First-Quarter-Financial-Results-Release-Conference-Call-and-Video-We-46225297/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
"language": "en",
"published_at": "2024-03-18T21:06:01.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "NG",
"name": "NovaGold Resources Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 47.317837,
"sentiment_score": 0,
"highlights": [
{
"highlight": "VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) -- <em>NOVAGOLD</em> <em>RESOURCES</em> <em>INC</em>. (TSX, NYSE American: NG) will release its 2024 first quarter financial results after market close on April 3, 2024. A conference call and video webcast to discuss these results will take place April 4, 2024, at 8:00 am PT (11:00 am ET).",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "5d96ee2a-836e-4f5f-8ae1-3248bd3b9626",
"title": "SAVE THE DATE: NOVAGOLD 2024 First Quarter Financial",
"description": "VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (TSX, NYSE American: NG) will release its 2024 first quarter...",
"keywords": "Toronto Stock Exchange:NG, NOVAGOLD RESOURCES INC.",
"snippet": "VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (TSX, NYSE American: NG) will release its 2024 first quarter financial r...",
"url": "https://www.globenewswire.com/news-release/2024/03/18/2848201/0/en/SAVE-THE-DATE-NOVAGOLD-2024-First-Quarter-Financial-Results-Release-Conference-Call-and-Video-Webcast.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/d0d86d39-79d9-43d5-b6c4-587b5276ae6c",
"language": "en",
"published_at": "2024-03-18T21:05:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "NG",
"name": "NovaGold Resources Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 47.317837,
"sentiment_score": 0,
"highlights": [
{
"highlight": "VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) -- <em>NOVAGOLD</em> <em>RESOURCES</em> <em>INC</em>. (TSX, NYSE American: NG) will release its 2024 first quarter financial results after market close on April 3, 2024. A conference call and video webcast to discuss these results will take place April 4, 2024, at 8:00 am PT (11:00 am ET).",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NYSEAMERICAN",
"total_documents": 99,
"sentiment_avg": 0.40023596847818776
}
]
}
Other details
Country
- us
- 6,709